StonvexLoading…
StonvexStonvexStonvexCore line items from SNPS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-30 | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 |
|---|---|---|---|---|
Revenue | $4.68B | $2.41B | $7.05B | $4.80B |
Operating Income | $323.47M | $203.05M | $914.93M | $793.53M |
Net Income | $82.06M | $64.96M | $1.33B | $883.52M |
EPS (Diluted) | $0.43 | $0.34 | $8.04 | $5.59 |
Total Assets | $46.89B | $47.24B | $48.22B | $48.23B |
Total Liabilities | $16.41B | $16.69B | $19.90B | $20.62B |
Cash & Equivalents | $2.41B | $2.13B | $2.89B | $2.53B |
Free Cash Flow OCF − CapEx | $1.40B | $821.51M | $1.35B | $743.96M |
Shares Outstanding | 191.44M | 191.45M | 185.99M | 185.46M |